Xu et al. [18] found that higher levels of CRP were associated with increasing lung cancer risk (OR = 2.11, 95% CI = 1.66–2.91, P < 0.01), suggesting that CRP could be used as surrogate biomarker of angiogenesis and prognosis in lung cancer. This evidence concerns the gene CRP and lung carcinoma.